期刊文献+

类风湿性关节炎膝关节高频超声改变与实验室检查相关性研究

下载PDF
导出
摘要 目的应用高频超声观察类风湿性关节炎(RA)患者治疗前后膝关节改变及其与实验室检查结果的相关性。方法RA患者102例,应用高频超声观察治疗前后膝关节滑膜厚度、滑膜血流分级、关节腔积液深度及股骨内外髁软骨厚度,分析其与抗环瓜氨酸肽抗体(Anti-CCP)、类风湿因子(RF)、C-反应蛋白(CRP)及血沉(ESR)的相关性。结果治疗达缓解标准后,患者膝关节滑膜较治疗前变薄、滑膜血流减少、关节腔积液减少,差异有显著性(P<0.01),股骨内外髁软骨厚度治疗前后差异无显著性(P>0.05);治疗前滑膜厚度与Anti-CCP(r=0.52,P<0.01),CRP(r=0.46,P<0.05)及ESR(r=0.48,P=0.01)呈正相关,关节腔积液深度与Anti-CCP(r=0.48,P=0.01),CRP(r=0.43,P<0.05)及ESR(r=0.40,P<0.05)呈正相关,而与RF无相关性(P>0.05);治疗后超声相关指标与实验室检查之间均无相关性(P>0.05)。结论高频超声可以较准确地评估RA临床疗效,结合实验室检查能提高临床诊断水平、正确判断疾病活动度,且较实验室检查更敏感、直观。
机构地区 甘肃省人民医院
出处 《卫生职业教育》 2018年第5期148-150,共3页 HEALTH VOCATIONAL EDUCATION
基金 甘肃省自然科学基金项目"高频超声及超声造影在RA膝关节病变的表现与血清VEGF表达的相关性研究"(1506RJZA174)
  • 相关文献

参考文献5

二级参考文献36

  • 1肖萤,张桂英,左小霞,罗卉,游运辉.高分辨力超声检查在类风湿关节炎膝肘腕关节滑膜炎的应用[J].中华风湿病学杂志,2006,10(2):94-97. 被引量:21
  • 2Bas S, Perneger TV, Seitz M, et al. Diagnostic tests for rheumatoid arthritis: comparison of anti-cycLic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factor. Rheumatology (Oxford), 2002, 41: 809-814.
  • 3Schellekens GA, Visser H, de Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum, 2000, 43: 155-163.
  • 4Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic disease. Ann Rheum Dis, 2003, 62: 870-874.
  • 5Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum, 2004, 50: 709-715.
  • 6Silveira IG, Burlingame RW, yon Muhlen CA, et al. Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF. Clin Rheumatol, 2007, 26: 1883-1889.
  • 7Quinn MA, Goagh AK, Green M J, et al. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology ( Oxford ), 2006, 45:478 -480.
  • 8del Val del Amo N, Ibanez-Bosch R, Fito-Manteca C, et al. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. Clin Exp Rheumatol, 2006, 24: 281-286.
  • 9Inanc N, Dalkilic E, Kamali S, et al. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol, 2007, 26: 17-23.
  • 10Bas S, Genevay S, Meyer O, et al. Anti-cyclic citrullinated peptide antibodies, IgM and lgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford), 2003, 42: 677-680.

共引文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部